Atlas Legacy Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 2054111 LOS ANGELES, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,893,899

+$840,764 QoQ

Shares Held

1,579

+37.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.16%

of 13F equity value

Holder Rank

#2,542

of 4,605 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 72% Shared 28% None 0%

Healthcare · as of Jun 30, 2026

Atlas Legacy Advisors, LLC holds $5,121,297 across 6 Drug Manufacturers - General names. LLY ranks #1 (37.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,579	$1,893,899
2	JNJ	Johnson & Johnson	4,361	$1,107,562
3	ABBV	AbbVie Inc.	2,607	$656,025
4	AMGN	Amgen Inc	1,644	$595,324
5	MRK	Merck & Co., Inc.	4,578	$588,272
6	NVS	Novartis AG	1,788	$280,215

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,893,899	1,579	+37.9%	Shares	Sole	2026-07-31
2026-03-31	$1,053,135	1,145	-25.9%	Shares	Sole	2026-05-11
2025-12-31	$1,661,455	1,546	+5.4%	Shares	Other	2026-01-29
2025-09-30	$1,119,321	1,467	+94.6%	Shares	Other	2025-10-30
2025-06-30	$587,765	754	-2.2%	Shares	Sole	2025-08-06
2025-03-31	$636,776	771	+0.9%	Shares	Sole	2025-05-07
2024-12-31	$589,808	764	—	Shares	Sole	2025-01-31
No filing history on record for this holder in this stock.